Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis

Abstract The non-vitamin K antagonist oral anticoagulants (NOACs) were approved for non-valvular atrial fibrillation (AF) but this term may be misnomer. Thus, the term non-mechanical and rheumatic mitral valvular (non-MARM) AF was proposed to exclude patients with valvular heart disease (VHD) withou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal. Cardiovascular pharmacotherapy 2018-04, Vol.4 (2), p.111-118
Hauptverfasser:	Caldeira, Daniel, David, Cláudio, Costa, João, Ferreira, Joaquim J, Pinto, Fausto J
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Anticoagulants Anticoagulants - administration & dosage Apixaban Atrial fibrillation Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Brain hemorrhage Cardiac arrhythmia Cardiac patients Cardiovascular disease Cardiovascular diseases Comparative analysis Complications and side effects Diet therapy Embolism Embolisms Evidence-based medicine Fibrillation Heart Heart diseases Heart valve diseases Heart Valve Diseases - complications Heart Valve Diseases - drug therapy Hemorrhage Humans Meta-analysis Risk Factors Rivaroxaban Systematic review Thromboembolism - etiology Thromboembolism - prevention & control Vitamin K - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!